Skip to content

Opening book details…

About this Medicine article

Impacto presupuestario del tratamiento en segunda línea de los pacientes con linfoma folicular en recaída o refractario a rituximab, con 90Y-ibritumomab tiuxetan en lugar de los tratamientos habituales by Carlos Rubio-Terrés,José Gómez Codina... is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Carlos Rubio-Terrés,José Gómez Codina...
Publisher
Springer-Verlag; Springer International Publishing AG; Springer Science and Business Media LLC (ISSN 1695-405X)
Published
2007
Field
Medicine (Health Sciences)

More by Carlos Rubio-Terrés,José Gómez Codina...

Browse all works by Carlos Rubio-Terrés,José Gómez Codina...